Cargando…

MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal Transition

[Image: see text] Purpose: the present study aims to investigate the function of miR-199 on gemcitabine (GEM)-resistance in pancreatic cancer, as well as the underlying mechanism. Methods: the GEM-resistant SW1990 cell line (SW1990/SZ) was established. The CCK-8 assay was used to detect the cell via...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Weitian, Wang, Liang, Xu, Liwei, Liang, Jinxiao, Teng, Lisong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637594/ https://www.ncbi.nlm.nih.gov/pubmed/34869970 http://dx.doi.org/10.1021/acsomega.1c02945

Ejemplares similares

Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition
por: Wei, Weitian, et al.
Publicado: (2022)

Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
por: Ma, Jia, et al.
Publicado: (2015)

miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
por: Hiramoto, Hidekazu, et al.
Publicado: (2017)

MiR-199a-3p Induces Mesenchymal to Epithelial Transition of Keratinocytes by Targeting RAP2B
por: Masalha, Moamen, et al.
Publicado: (2022)

SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer
por: Zhao, X, et al.
Publicado: (2014)

miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition
por: Zhao, Zhigang, et al.
Publicado: (2020)

miR-539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1
por: Xue, Liang, et al.
Publicado: (2020)

Correction: miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition
por: Zhao, Zhigang, et al.
Publicado: (2021)

miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion
por: Chen, Dahu, et al.
Publicado: (2014)

hsa-miR-199b-3p suppresses osteosarcoma progression by targeting CCDC88A, inhibiting epithelial-to-mesenchymal transition, and Wnt/beta-catenin signaling pathway
por: Zhu, Dongsheng, et al.
Publicado: (2023)

Aspirin increases the efficacy of gemcitabine in pancreatic cancer by modulating the PI3K/AKT/mTOR signaling pathway and reversing epithelial‑mesenchymal transition
por: Zhou, Hanyu, et al.
Publicado: (2023)

MiR-205 suppressed the malignant behaviors of breast cancer cells by targeting CLDN11 via modulation of the epithelial-to-mesenchymal transition
por: Shen, Yupeng, et al.
Publicado: (2021)

Restoration of miR-1228* Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer
por: Jia, Litao, et al.
Publicado: (2013)

Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells
por: Wang, Qian, et al.
Publicado: (2017)

The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells
por: Wang, Rui, et al.
Publicado: (2015)

MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
por: Lu, Yuhua, et al.
Publicado: (2014)

Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters
por: Wu, Ying-Si, et al.
Publicado: (2021)

MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer
por: Wu, Chia-Lun, et al.
Publicado: (2016)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

MicroRNA-199b-5p attenuates TGF-β1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
por: Zhou, Shao-jun, et al.
Publicado: (2017)

hsa-miR-24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c-Myc/epithelial-mesenchymal transition axis
por: Su, Bojin, et al.
Publicado: (2018)

miR-1-3p suppresses the epithelial-mesenchymal transition property in renal cell cancer by downregulating Fibronectin 1
por: Liu, Jianghui, et al.
Publicado: (2019)

Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
por: Maier, Harald J., et al.
Publicado: (2010)

Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma
por: Cano, Carla, et al.
Publicado: (2010)

TRIM50 Suppresses Pancreatic Cancer Progression and Reverses the Epithelial-Mesenchymal Transition via Facilitating the Ubiquitous Degradation of Snail1
por: Li, Rongkun, et al.
Publicado: (2021)

Keratin 17 Suppresses Cell Proliferation and Epithelial-Mesenchymal Transition in Pancreatic Cancer
por: Zeng, Yong, et al.
Publicado: (2020)

The effect and mechanism of miR-30e-5p targeting SNAI1 to regulate epithelial-mesenchymal transition on pancreatic cancer
por: Liang, Ziyu, et al.
Publicado: (2022)

Doxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cells
por: Qin, Yuan, et al.
Publicado: (2015)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

Reply to ‘Comment on ‘MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma’’
por: Zhou, Shao-jun, et al.
Publicado: (2018)

MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression
por: Zhang, Ying, et al.
Publicado: (2014)

Exosomal miR‐1255b‐5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial‐to‐mesenchymal transition
por: Zhang, Xue, et al.
Publicado: (2020)

MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets
por: Chen, Shu-peng, et al.
Publicado: (2015)

MiR‐577 suppresses epithelial‐mesenchymal transition and metastasis of breast cancer by targeting Rab25
por: Yin, Chonggao, et al.
Publicado: (2018)

miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis
por: Liu, Yankun, et al.
Publicado: (2017)

miR-665 Suppresses the Epithelial–Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1
por: Wu, Kun-Zhe, et al.
Publicado: (2020)

miR-381-3p suppresses breast cancer progression by inhibition of epithelial–mesenchymal transition
por: Yu, Yong-Zheng, et al.
Publicado: (2021)

MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4
por: Hu, Jiajia, et al.
Publicado: (2012)

Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
por: Zhang, Kun, et al.
Publicado: (2020)

Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207
por: You, Lei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s0r3ep1e3epesl567jarn91spb